Central Alerting System
View Alert

Originator: National Patient Safety Alert - DHSC

Issue date: 03-Jan-2024 11:19:31

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Director of Public Health
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • Integrated Care Boards
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Shortage of GLP-1 receptor agonists (GLP-1 RA) update

Broadcast content:

The supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to be limited, with supply not expected to return to normal until at least the end of 2024. The supply issues have been caused by an increase in demand for these products for licensed and off-label indications.

This National Patient Safety Alert provides further background and clinical information and actions for providers.

This NatPSA supersedes NatPSA/2023/008/DHSC.

Additional information: NHS England Regions: please cascade this National Patient Safety Alert to Community Pharmacy.

Alert reference: NatPSA/2024/001/DHSC

Action underway deadline: 05-Jan-2024

Action complete deadline: 28-Mar-2024


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency